2011

DATATRAK named CDISC Registered Solutions Provider

Tuesday, December 6, 2011

DATATRAK International has been recognized as a CDISC Registered Solutions Provider. DATATRAK has been registered as a CDISC consultant, system integrator and subject matter expert in the following CDISC standards: Clinical Data Acquisition Standards Harmonization (CDASH); Laboratory Data Model (LAB); Operational Data Model (ODM); Study Data Tabulation Model (SDTM).

[Read More]

Merck establishes R&D headquarters in China

Tuesday, December 6, 2011

Merck, known as MSD outside the United States and Canada, has established an Asia research & development headquarters for innovative drug discovery and development located in Beijing, China. The new facility is part of a $1.5 billion commitment the company has made to invest in R&D in China over the next five years.

[Read More]

AstraZeneca, MRC ink collaboration giving UK academia access to 22 compounds

Monday, December 5, 2011

A wide range of compounds will be made available free of charge to UK medical researchers next year, following an agreement between the Medical Research Council (MRC) and AstraZeneca. Academia will be granted access to 22 compounds, developed by AstraZeneca. Through MRC funding, UK academia will conduct studies to better understand what drives a range of diseases with a view to exploring new treatment opportunities.

[Read More]